Pharmacy
Rivaroxaban Reduces Symptomatic VTE & Death Following Knee or Hip Replacement Surgery
The FINANCIAL -- Results from a pre-specified pooled analysis of the RECORD clinical trial program showed that the novel, investigational,...
Chris Viehbacher takes up his position as Chief Executive Officer
The FINANCIAL -- Sanofi-aventis announced that Mr. Chris Viehbacher has taken up his position on December 1 as Chief Executive Officer of the...
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
The FINANCIAL -- Johnson & Johnson (NYSE: JNJ) and Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI), a fully integrated biopharmaceutical company that...
New phase III study of Avastin in advanced breast cancer
The FINANCIAL -- Roche announced on November 24 that the Avastin study RIBBON-1 met its primary endpoint of increasing the time women...
Start of Phase III Trial on the Anti-influenza Drug CS-8958
The FINANCIAL -- Daiichi Sankyo Co., Ltd. on November 17 announced that its anti-influenza drug, CS-8958, has started it's pivotal Phase III...
Bayer builds new chlorine recycling plant for TDI production in Shanghai
The FINANCIAL -- Bayer MaterialScience plans to build another chlorine recycling plant at the Bayer Integrated Site Shanghai (BISS).
Demands for Medical Business Management Increasing
The FINANCIAL -- While job opportunities are decreasing in financial sectors because of the global crisis, perspectives for medical management...
Urgent need for social and psychological support for young people with diabetes
The FINANCIAL -- A global survey studying children with diabetes has identified a failure of current healthcare systems to give...
Sanofi Pasteur First International Vaccine Company to Enter Japan with Pediatric vaccine
The FINANCIAL -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced on November 10 that it is the first international vaccine...
Lilly: Long-term benefits of preventing heart attacks highlighted in new study presented
The FINANCIAL -- Despite substantial progress in the diagnosis and treatment of heart attack patients, prevention of recurrent heart attacks continues...
Moms Raise “Red Flag” about the Dangers of Widely Undiagnosed Bleeding Disorder
The FINANCIAL -- While an estimated 2.8 million Americans are affected by the most common hereditary bleeding disorder, von Willebrand...
Gilead Announces 2-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatit
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq:GILD) on November 1 announced the presentation of two-year (96-week) data from two Phase III pivotal...
Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens
The FINANCIAL -- Schering-Plough Corporation (NYSE: SGP) on November 1 reported that a planned interim analysis of a Phase II study showed that...
New Data Suggest Long-Term Treatment with BARACLUDE May Reduce Liver Damage
The FINANCIAL -- Bristol-Myers Squibb Company (NYSE:BMY) on November 2 announced data from two separate cohort evaluations, in which long-term treatment with...
Schering-Plough: Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppress
The FINANCIAL -- Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA 2008 Annual Meeting Schering-Plough Corporation...
ADVERTISEMENT
Popular Last 24h
-
Justice Department Files Voting Rights Suit Against City of Hazleton, Pennsylvania
-
Crews battle fire at Cleveland Metroparks Zoo’s Rainforest exhibit
-
Ampersand wins £22m five-year contract at London Zoo
-
The UK Government has announced a full asset freeze against Blood and Honour.
-
Boston Calling 2025 lineup: Dave Matthews Band, Luke Combs, and Fall Out Boy to headline
-
Meta Will Test Showing EBay Listings On Facebook Marketplace. EBay Stock Jumps.
-
eal Estate Lessons That We’re Taking Into 2025
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
